The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease
Top Cited Papers
Open Access
- 1 December 2002
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 73 (6) , 629-635
- https://doi.org/10.1136/jnnp.73.6.629
Abstract
Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.Keywords
This publication has 18 references indexed in Scilit:
- Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndromeActa Neurologica Scandinavica, 2009
- Parkinson’s disease and sleepinessNeurology, 2002
- Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PDNeurology, 2002
- Evaluation of somnolence in Parkinson’s disease: Comparison with age- and sex-matched controlsNeurology, 2002
- Daytime sleepiness and other sleep disorders in Parkinson’s diseaseNeurology, 2001
- Achieving 24-Hour Control of Parkinson’s Disease Symptoms: Use of Objective Measures to Improve Nocturnal DisabilityEuropean Neurology, 2001
- Measuring quality of life: Who should measure quality of life?BMJ, 2001
- Improvement of sleep architecture in PD with subthalamic nucleus stimulationNeurology, 2000
- Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based studyMovement Disorders, 1999
- Sleep in patients with Parkinson's disease and normal subiects prior to and following levodopa administrationClinical Pharmacology & Therapeutics, 1971